Opsonix picks up $8 mln Series A
Cambridge, Massachusetts-based Opsonix, a developer of pathogen-extracting treatments focused on treating blood borne infectious diseases, has launched with $8 million in Series A funding. Baxter Ventures led the round.
9 October 2015•5 mins read
